Friday, 27 November 2020

Biogen Bets On Depression Drug In $1.5 Billion Deal With Sage Therapeutics

Biogen Inc will take a $650 million stake in Sage Therapeutics and make an upfront payment of $875 million to jointly develop and sell treatments for depression and other neurological disorders, the two companies said on Friday.

from Top Business News- News18.com https://ift.tt/2KMSHwN
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Beyond Borders: The True Origins Of India's Favorite Brands - Colgate, Bata And Maruti

Bata grew into one of the world's leading shoemakers, with an impressive annual sale of 150 million pairs of shoes across more than 70 c...